Immune checkpoint inhibitors for patients with cancer may be associated with an increased risk for psoriasis when compared ...

Phase 1b trial designed to provide key insights into VYN202’s potential across a range of chronic, immune-mediated diseases BRIDGEWATER, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc.

Unexpected skin disorders might be a sign of high cholesterol, a silent threat that affects heart health. Discover how to ...